Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 14Neoplasms 11Carcinoma, Non-Small-Cell Lung 10Colorectal Neoplasms 9Prostatic Neoplasms 8Lung Neoplasms 7Melanoma 6Pancreatic Neoplasms 5Head and Neck Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Neoplastic Cells, Circulating 4Hematologic Neoplasms 4Stomach Neoplasms 3Neoplasm Metastasis 3Leukemia, Myeloid, Acute 3Leukemia 3Glioblastoma 3Carcinoma, Hepatocellular 3Uterine Cervical Neoplasms 2Thyroid Neoplasms 2Sarcoma 2Recurrence 2Ovarian Neoplasms 2Oropharyngeal Neoplasms 2Myelodysplastic Syndromes 2Lymphoma, Non-Hodgkin 2Liver Diseases 2Kidney Neoplasms 2Glioma 2Fibrosis 2

Interventions

sintilimab 1Vascular Access Devices 1Quality of Life 1Portasystemic Shunt, Transjugular Intrahepatic 1Nutritional Status 1Interviews as Topic 1Hyperthermic Intraperitoneal Chemotherapy 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Ascites × Blood Specimen Collection × Clear all
NCT06046963 2023-09-21

Sintilimab in Combination With S-1/Oxaliplatin With Nab-paclitaxel Intraperitoneal Infusion for Untreated Advanced Gastric Cancer With Malignant Ascites

Zhejiang Cancer Hospital

Phase 2 Unknown
35 enrolled
Gastrointestinal

Ascites, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡